Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Star Bulk Carriers
SBLK
$3.45B
| $286K | ﹤0.01% |
+63,094
| New | +$266K |
2016 Q3
0 quarters
|
|
|
SCTL
2977
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $286K | ﹤0.01% |
+36,126
| New | +$290K |
2016 Q3
0 quarters
|
|
|
EDR
2978
DELISTED
Education Realty Trust Inc
EDR
| $285K | ﹤0.01% |
6,600
-102,100
| -94% | -$4.67M |
2014 Q4
7 quarters
|
|
|
PFBX
2979
DELISTED
Peoples Financial Corp/MS
PFBX
| $282K | ﹤0.01% |
26,500
+1,600
| +6% | +$16.8K |
2014 Q4
7 quarters
|
|
|
IVC
2980
DELISTED
Invacare Corporation
IVC
| $281K | ﹤0.01% |
25,200
-297,200
| -92% | -$3.58M |
2015 Q2
5 quarters
|
|
|
PRTY
2981
DELISTED
Party City Holdco Inc.
PRTY
| $281K | ﹤0.01% |
+16,400
| New | +$273K |
2016 Q3
0 quarters
|
|
2982
Mind CTI
MNDO
$19.2M
| $280K | ﹤0.01% |
128,900
+20,500
| +19% | +$44.1K |
2013 Q2
13 quarters
|
|
2983
Microbot Medical
MBOT
$71.9M
| $279K | ﹤0.01% |
1,520
+980
| +181% | +$128K |
2015 Q3
4 quarters
|
|
2984
US Global Investors
GROW
$36M
| $278K | ﹤0.01% |
150,900
+18,300
| +14% | +$37.5K |
2014 Q4
7 quarters
|
|
|
WSCI
2985
DELISTED
WSI Industries Inc
WSCI
| $276K | ﹤0.01% |
75,100
+4,200
| +6% | +$14K |
2013 Q2
13 quarters
|
|
2986
ACNB Corp
ACNB
$633M
| $274K | ﹤0.01% |
10,300
-1,500
| -13% | -$39.5K |
2016 Q2
1 quarter
|
|
|
EHIC
2987
DELISTED
eHi Car Services Limited
EHIC
| $272K | ﹤0.01% |
+26,500
| New | +$280K |
2016 Q3
0 quarters
|
|
|
EVOK
2988
DELISTED
Evoke Pharma
EVOK
| $271K | ﹤0.01% |
833
+702
| +536% | +$321K |
2016 Q2
1 quarter
|
|
|
ONCS
2989
DELISTED
OncoSec Medical Incorporated
ONCS
| $269K | ﹤0.01% |
716
+156
| +28% | +$59.7K |
2016 Q1
2 quarters
|
|
|
IMUC
2990
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $269K | ﹤0.01% |
56,938
+20,625
| +57% | +$133K |
2014 Q4
7 quarters
|
|
|
KZIA
2991
Kazia Therapeutics
KZIA
$139M
| $268K | ﹤0.01% |
687
| – | – |
2015 Q1
6 quarters
|
|
|
HNR
2992
DELISTED
Harvest Natural Resources
HNR
| $267K | ﹤0.01% |
82,350
+47,150
| +134% | +$125K |
2016 Q1
2 quarters
|
|
|
DCOY
2993
Decoy Therapeutics
DCOY
$963K
| – | – |
0
| – | – |
2016 Q2
1 quarter
|
|
|
ADYX
2994
DELISTED
Adynxx Inc
ADYX
| $266K | ﹤0.01% |
5,550
+1,025
| +23% | +$63.6K |
2015 Q3
4 quarters
|
|
|
SGM
2995
DELISTED
Stonegate Mortgage Corporation
SGM
| $263K | ﹤0.01% |
57,400
+12,700
| +28% | +$48.4K |
2016 Q1
2 quarters
|
|
|
PFIE
2996
DELISTED
Profire Energy, Inc
PFIE
| $261K | ﹤0.01% |
210,200
+75,114
| +56% | +$90.2K |
2015 Q4
3 quarters
|
|
|
GRO
2997
DELISTED
Agria Corp
GRO
| $261K | ﹤0.01% |
314,200
+27,700
| +10% | +$23.2K |
2013 Q2
13 quarters
|
|
2998
Tonix Pharmaceuticals
TNXP
$125M
| – | – |
0
| – | – |
2016 Q2
1 quarter
|
|
2999
Parke Bancorp
PKBK
$379M
| $258K | ﹤0.01% |
+22,733
| New | +$241K |
2016 Q3
0 quarters
|
|
|
RELV
3000
DELISTED
Reliv International Inc
RELV
| $258K | ﹤0.01% |
53,500
+2,829
| +6% | +$14.6K |
2013 Q2
13 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.